WO2001023018A3 - Intranasal delivery system - Google Patents
Intranasal delivery system Download PDFInfo
- Publication number
- WO2001023018A3 WO2001023018A3 PCT/US2000/026870 US0026870W WO0123018A3 WO 2001023018 A3 WO2001023018 A3 WO 2001023018A3 US 0026870 W US0026870 W US 0026870W WO 0123018 A3 WO0123018 A3 WO 0123018A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dose
- delivery
- administrator
- aperture
- stream
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/0081—Locking means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/07—General characteristics of the apparatus having air pumping means
- A61M2205/071—General characteristics of the apparatus having air pumping means hand operated
- A61M2205/073—Syringe, piston type
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00967128A EP1225941A4 (en) | 1999-09-29 | 2000-09-29 | Intranasal delivery system |
CA002386110A CA2386110C (en) | 1999-09-29 | 2000-09-29 | Intranasal delivery system |
US10/089,224 US7204822B1 (en) | 1999-09-29 | 2000-09-29 | Intranasal delivery system |
AU77376/00A AU774757B2 (en) | 1999-09-29 | 2000-09-29 | Intranasal delivery system |
US10/941,727 US7678087B2 (en) | 1999-09-29 | 2004-09-15 | Equine intranasal delivery system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/408,584 US6398774B1 (en) | 1999-09-29 | 1999-09-29 | Intranasal delivery system |
US09/408,584 | 1999-09-29 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US40854899A Continuation | 1999-09-29 | 1999-09-29 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10089244 A-371-Of-International | 2000-09-29 | ||
US10/941,727 Continuation US7678087B2 (en) | 1999-09-29 | 2004-09-15 | Equine intranasal delivery system |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001023018A2 WO2001023018A2 (en) | 2001-04-05 |
WO2001023018A3 true WO2001023018A3 (en) | 2001-12-06 |
Family
ID=23616876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/026870 WO2001023018A2 (en) | 1999-09-29 | 2000-09-29 | Intranasal delivery system |
Country Status (5)
Country | Link |
---|---|
US (2) | US6398774B1 (en) |
EP (1) | EP1225941A4 (en) |
AU (4) | AU774757B2 (en) |
CA (3) | CA2640663C (en) |
WO (1) | WO2001023018A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6398774B1 (en) * | 1999-09-29 | 2002-06-04 | Heska Corporation | Intranasal delivery system |
US6651655B1 (en) * | 2000-01-18 | 2003-11-25 | Quadrant Technologies Limited | Inhaled vaccines |
US20040039352A1 (en) * | 2002-06-28 | 2004-02-26 | Paul Bergeson | Nasal dosing device |
WO2005014778A2 (en) * | 2003-05-15 | 2005-02-17 | The Board Of Regents For Oklahoma State University | Dna vaccine expressing ha1 of equine-2 influenza virus |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US9358150B2 (en) | 2005-05-13 | 2016-06-07 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance |
US7824436B2 (en) * | 2005-05-13 | 2010-11-02 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
US8721699B2 (en) | 2005-05-13 | 2014-05-13 | Benechill, Inc. | Methods and devices for non-invasive cerebral and systemic cooling |
ES2496315T3 (en) | 2005-10-19 | 2014-09-18 | University Of Florida Research Foundation, Incorporated | Materials for the control of respiratory disease in canines |
WO2008005577A2 (en) * | 2006-07-07 | 2008-01-10 | University Of South Florida | Compositions of polyphenols and methods of use |
US7749191B2 (en) * | 2008-03-20 | 2010-07-06 | Beutlich Lp, Pharmaceuticals | Device and method for drug delivery |
US8015873B2 (en) * | 2008-04-25 | 2011-09-13 | Hall David L | Detector housing |
US20100174278A1 (en) * | 2008-11-07 | 2010-07-08 | Denise Barbut | Methods of nasopharyngeal cooling for augmenting coronary perfusion pressure |
WO2010142017A1 (en) | 2009-06-09 | 2010-12-16 | Defyrus, Inc . | Administration of interferon for prophylaxis against or treatment of pathogenic infection |
WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
CN102802717A (en) * | 2009-06-19 | 2012-11-28 | 贝尼奇尔股份有限公司 | Devices for cooling the nasal cavity |
CN114010776A (en) | 2010-06-09 | 2022-02-08 | 疫苗技术股份有限公司 | Therapeutic immunization of HIV-infected persons for enhancing antiretroviral therapy |
EP2706991B1 (en) | 2011-05-11 | 2021-03-24 | Children's Medical Center Corporation | Multiple antigen presenting immunogenic composition, and methods and uses thereof |
JP6494527B2 (en) | 2013-02-07 | 2019-04-03 | ザ チルドレンズ メディカル センター コーポレーション | Protein antigens that provide protection from pneumococcal colonization and / or disease |
CA3030225A1 (en) * | 2016-07-20 | 2018-01-25 | Elanco Us Inc. | Animal intranasal administration device, systems, and associated methods |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5601077A (en) * | 1991-08-07 | 1997-02-11 | Becton, Dickinson And Company | Nasal syringe sprayer with removable dose limiting structure |
US5720762A (en) * | 1996-06-24 | 1998-02-24 | Bass; Lawrence S. | Device and method for surgical flap dissection |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950512A (en) | 1972-07-25 | 1976-04-13 | Pitman-Moore, Inc. | Animal vaccines |
US4009258A (en) | 1972-09-25 | 1977-02-22 | The Mount Sinai School Of Medicine Of The City University Of New York | Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same |
US3927208A (en) | 1973-05-14 | 1975-12-16 | Rit Rech Ind Therapeut | Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them |
US3953592A (en) | 1973-09-27 | 1976-04-27 | Recherche Et Industrie Therapeutiques (R.I.T.) | Live influenza virus vaccines and preparation thereof |
US4132775A (en) | 1973-12-03 | 1979-01-02 | Richardson-Merrell Inc. | Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same |
US4195076A (en) | 1974-03-05 | 1980-03-25 | Science Union Et Cie, Societe Francaise De Recherche Medicale | Process for the preparation of hemagglutinin from viral sources and methods of utilizing same |
FR2262962B1 (en) | 1974-03-05 | 1977-11-04 | Science Union & Cie | |
US4029763A (en) | 1974-08-05 | 1977-06-14 | Mount Sinai School Of Medicine Of The City University Of New York | Influenza vaccine containing purified neuraminidase antigen and method of using the same |
US3962422A (en) | 1975-02-18 | 1976-06-08 | Syntex (U.S.A.) Inc. | Method for immunizing nursing piglets against transmissible gastroenteritis(TGE) virus |
US4053583A (en) | 1976-03-01 | 1977-10-11 | Smithkline Corporation | Live newcastle disease virus vaccines |
US4110427A (en) | 1976-04-14 | 1978-08-29 | The Risdon Manufacturing Company | Powdered solid aerosol composition and method of manufacture |
US4110433A (en) | 1976-04-23 | 1978-08-29 | Philips Roxane, Inc. | Equine rhinopneumonitis virus |
US4512972A (en) | 1980-06-30 | 1985-04-23 | Kureha Chemical Industry Co., Ltd. | Nasal preparation and processes for their production |
US4554159A (en) | 1981-11-12 | 1985-11-19 | Institute Merieux | Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) |
US4683137A (en) | 1982-04-16 | 1987-07-28 | Cornell Research Foundation, Inc. | Temperature sensitive reassortant viruses and a vaccine against equine influenza |
GB8300467D0 (en) | 1983-01-08 | 1983-02-09 | Wellcome Found | Equine influenza |
JPS59163313A (en) | 1983-03-09 | 1984-09-14 | Teijin Ltd | Peptide hormone composition for nasal administration |
US4554158A (en) | 1983-04-07 | 1985-11-19 | Simonsen Laboratories, Inc. | Modified live sendai virus vaccine for administering through an aerosol and method of producing the same |
US4962091A (en) | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
US4767416A (en) * | 1986-12-01 | 1988-08-30 | Johnson & Johnson Patient Care, Inc. | Spray nozzle for syringe |
NZ224422A (en) | 1987-05-05 | 1990-11-27 | Molecular Eng Ass | Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid |
US4800078A (en) | 1987-05-28 | 1989-01-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb |
US5026825A (en) * | 1988-09-08 | 1991-06-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Intranasal calcitonin formulations |
US5250298A (en) | 1988-10-07 | 1993-10-05 | University Of Delaware | Live attenuated newcastle disease virus vaccines and preparation thereof |
US4923448A (en) * | 1988-12-06 | 1990-05-08 | Mark Anderson | Syringe with spray nozzle tip |
US5158761A (en) | 1989-04-05 | 1992-10-27 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
US5215739A (en) | 1989-04-05 | 1993-06-01 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
US5062423A (en) * | 1990-02-27 | 1991-11-05 | Minnesota Mining And Manufacturing Company | Equine aerosol drug delivery method and apparatus |
DE4016126A1 (en) * | 1990-04-17 | 1991-10-24 | Coster Tecnologie Speciali Spa | DEVICE FOR TRANSNASAL OR ORAL ADMINISTRATION OF MEDICATIONS OR THE LIKE |
US5053022A (en) * | 1990-06-28 | 1991-10-01 | Mobay Corporation | Applicator for intranasal administration of vaccines to horses |
IT1244803B (en) * | 1990-11-21 | 1994-09-05 | Promo Pack S A | SINGLE-DOSE DISPENSER-SPRAYER FOR ENDONASAL ADMINISTRATION OF LIQUID MEDICATIONS. |
US5331954A (en) * | 1990-12-21 | 1994-07-26 | Novo Nordisk A/S | Device for nasal delivery of liquid medications |
US5429599A (en) * | 1994-05-02 | 1995-07-04 | Heinke; Richard M. | Method and means for delivering a pharmaceutical into the nostril of an animal |
DE19518810A1 (en) * | 1995-05-26 | 1996-11-28 | Bayer Ag | Nasal applicator |
US5683137A (en) | 1996-05-15 | 1997-11-04 | Bright Ideas Group, Inc. | Time-out chair/seat |
US6398774B1 (en) * | 1999-09-29 | 2002-06-04 | Heska Corporation | Intranasal delivery system |
US6382204B1 (en) * | 1999-10-14 | 2002-05-07 | Becton Dickinson And Company | Drug delivery system including holder and drug container |
-
1999
- 1999-09-29 US US09/408,584 patent/US6398774B1/en not_active Expired - Lifetime
-
2000
- 2000-09-29 CA CA2640663A patent/CA2640663C/en not_active Expired - Lifetime
- 2000-09-29 US US10/089,224 patent/US7204822B1/en not_active Expired - Lifetime
- 2000-09-29 EP EP00967128A patent/EP1225941A4/en not_active Withdrawn
- 2000-09-29 WO PCT/US2000/026870 patent/WO2001023018A2/en active IP Right Grant
- 2000-09-29 CA CA002541848A patent/CA2541848C/en not_active Expired - Lifetime
- 2000-09-29 CA CA002386110A patent/CA2386110C/en not_active Expired - Lifetime
- 2000-09-29 AU AU77376/00A patent/AU774757B2/en not_active Expired
-
2004
- 2004-10-07 AU AU2004218666A patent/AU2004218666B2/en not_active Expired
-
2006
- 2006-11-14 AU AU2006236004A patent/AU2006236004B2/en not_active Expired
-
2008
- 2008-06-06 AU AU2008202537A patent/AU2008202537A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5601077A (en) * | 1991-08-07 | 1997-02-11 | Becton, Dickinson And Company | Nasal syringe sprayer with removable dose limiting structure |
US5720762A (en) * | 1996-06-24 | 1998-02-24 | Bass; Lawrence S. | Device and method for surgical flap dissection |
Non-Patent Citations (1)
Title |
---|
See also references of EP1225941A4 * |
Also Published As
Publication number | Publication date |
---|---|
AU2004218666B2 (en) | 2006-08-31 |
CA2541848A1 (en) | 2001-04-05 |
AU2006236004A1 (en) | 2006-12-07 |
AU2008202537A1 (en) | 2008-06-26 |
US6398774B1 (en) | 2002-06-04 |
CA2640663A1 (en) | 2001-04-05 |
AU2006236004B2 (en) | 2008-03-13 |
CA2386110C (en) | 2006-05-30 |
AU2004218666A1 (en) | 2004-11-04 |
EP1225941A4 (en) | 2007-07-11 |
WO2001023018A2 (en) | 2001-04-05 |
US7204822B1 (en) | 2007-04-17 |
CA2386110A1 (en) | 2001-04-05 |
CA2541848C (en) | 2008-12-02 |
AU7737600A (en) | 2001-04-30 |
AU774757B2 (en) | 2004-07-08 |
CA2640663C (en) | 2011-09-13 |
EP1225941A2 (en) | 2002-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001023018A3 (en) | Intranasal delivery system | |
WO2002060412A3 (en) | Stabilised polymeric aerosols for pulmonary gene delivery | |
KR970706018A (en) | VACCINE COMPOSITIONS | |
WO2006006963A3 (en) | Aerosol delivery systems and methods | |
WO2008094219A3 (en) | Pulse drug nebulization system, formulations therefore, and methods of use | |
ATE271383T1 (en) | POWDER FORMULATION FOR INHALATION | |
CY1124878T1 (en) | ORODIZED DOSAGE UNIT CONTAINING AN ESTETROL INGREDIENT | |
PL398576A1 (en) | Vaccine preparations, pharmaceutical preparations, attenuated influenza virus, vaccination methods, methods for the prevention of an infectious disease, methods of treatment or prevention of cancers, vaccine compositions and pharmaceutical compositions | |
EP1476138B8 (en) | Modified release formulations of at least one form of tramadol | |
EP1820853A3 (en) | Recombinant influenza viruses for vaccines and gene therapy | |
WO2004039428A3 (en) | Transdermal delivery system for dried particulate or lyophilized medications | |
DE69818707D1 (en) | CHITOSAN AND INFLUENZA-ANTIGEN (S) CONTAINING VACCINE PREPARATIONS FOR ADMINISTRATION BY A MUCOSA | |
HUP0400264A2 (en) | Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers and process for their preparation | |
BR9809448A (en) | Medical aerosol products. | |
WO2003000018A3 (en) | Dopamine agonist formulations for enhanced central nervous system delivery | |
HUP0203168A2 (en) | Compositions for mucosal delivery | |
EP2272950A3 (en) | Defective influenza virus particles | |
DZ3169A1 (en) | Systems and methods for aerosol spraying of pharmaceutical formulations. | |
JP2013126989A5 (en) | ||
WO2000050050A8 (en) | Multiparticulate formulation | |
BR9714299A (en) | Macromolecular compound, processes for the detection of influenza virus and treatment of influenza infection, pharmaceutical composition for this treatment and use of compound | |
WO2006088481A3 (en) | Genetically engineered equine influenza virus and uses thereof | |
NZ602217A (en) | Vaccines for influenza | |
BRPI0414321A (en) | high pressure sterilization for final sterilization of pharmaceutical and medical preparations | |
ATE406152T1 (en) | MEDICAL AEROSOL COMPOSITIONS HAVING AN EXCIPIENT COMPOUND CONTAINING AN AMIDE AND/OR ESTER GROUP |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10089224 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2386110 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 77376/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000967128 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000967128 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 77376/00 Country of ref document: AU |